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Pvr and cell growth <p>Pvr and its ligands, Pvf 2 and 3, which are upstream of Ras and PI3kinase, are identified from a genome-wide screen in Drosophila  cells, as regulators of cell growth.</p>
Abstract
Background:  In multicellular animals, cell size is controlled by a limited set of conserved
intracellular signaling pathways, which when deregulated contribute to tumorigenesis by enabling
cells to grow outside their usual niche. To delineate the pathways controlling this process, we
screened a genome-scale, image-based Drosophila RNA interference dataset for double-stranded
RNAs that reduce the average size of adherent S2R+ cells.
Results: Automated analysis of images from this RNA interference screen identified the receptor
tyrosine kinase Pvr, Ras pathway components and several novel genes as regulators of cell size.
Significantly, Pvr/Ras signaling also affected the size of other Drosophila cell lines and of larval
hemocytes. A detailed genetic analysis of this growth signaling pathway revealed a role for
redundant secreted ligands, Pvf2 and Pvf3, in the establishment of an autocrine growth signaling
loop. Downstream of Ras1, growth signaling was found to depend on parallel mitogen-activated
protein kinase (MAPK) and phospho-inositide-3-kinase (PI3K) signaling modules, as well as the Tor
pathway.
Conclusions: This automated genome-wide screen identifies autocrine Pvf/Pvr signaling, upstream
of Ras, MAPK and PI3K, as rate-limiting for the growth of immortalized fly cells in culture. Since,
Pvf2/3 and Pvr show mutually exclusive in vivo patterns of gene expression, these data suggest that
co-expression of this receptor-ligand pair plays a key role in driving cell autonomous growth during
the establishment of Drosophila  cell lines, as has been suggested to occur during tumor
development.
Background
Tissue growth is regulated by a balance of cell growth, prolif-
eration and apoptosis. In many systems, however, cell prolif-
eration and the accumulation of individual cell mass (cell
growth) have been shown to be regulated independently,
including in mammalian cells [1], fly cells [2] and yeast [3].
This is explained in part by the action of distinct signaling
pathways [4]. Ras-Mitogen-activated protein kinase (MAPK)
signaling plays the predominant role in the promotion of cell
proliferation in mammalian cells, while phospho-inositide-3-
kinase (PI3K) and Tor signaling pathways primarily control
the ability of individual cells to accumulate mass, through the
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promotion of ribosome biogenesis and protein translation
[5]. To maintain cell size during tissue growth it is therefore
important that increases in cell proliferation and the rate of
mass accumulation be coordinated. One way to do this is via
pathway crosstalk, and there is increasing evidence for direct
crosstalk between growth and proliferation signals during
normal development [6,7] and in diseased states [7-9]. His-
torically, screens for genes controlling cell proliferation and
growth have been carried out in a tissue context in the animal
[10]. Since the discovery of RNA interference (RNAi) [11],
however, several groups have taken advantage of the ability to
carry out systematic, genome-scale RNAi screens in Dro-
sophila cell culture [12-15] to address this problem. Through
the design of luciferase and fluorescence activated cell sorting
(FACS) based RNAi screens, large numbers of genes have
been identified that regulate overall population growth, cell
cycle progression, cell size, cell viability and Ras-MAPK sign-
aling [13-15]. In addition, methods have been developed to
carry out high content cell-based RNAi screens in Drosophila
cell culture [16]. Whilst the analysis of such data sets repre-
sents a challenge, computational tools have recently been
developed that allow an automated analysis of phenotypes
from cell images [17]. We have used an automated image
analysis pipeline to screen images from a genome-scale, high-
content RNAi screen (Sims et al., unpublished data) for genes
that limit the average size of adherent hemocyte-derived
S2R+ cells [16,18]. In this way, we have identified a novel role
for autocrine Pvf/Pvr signaling, upstream of both Ras and
phospho-inositide-3-kinase (PI3K), as a rate-limiting step in
the regulation of Drosophila cell size.
Results
A genome-scale RNAi screen reveals genes that 
regulate cell size
To identify regulators of Drosophila  cell size, a library of
approximately 22,000 double-stranded RNAs (dsRNAs) cov-
ering 91% of the Drosophila genome [14] was screened in
384-well plates. After 5 days of RNAi treatment, S2R+ cells
were stained to visualize F-actin, microtubules and DNA and
imaged by automated microscopy (Figure 1). The resulting
images were computationally analyzed to identify dsRNAs
that led to a reduction in average cell area. First, regions of
each image containing a monolayer of adherent cells were
identified using an algorithm that removes cell clumps and
non-cellular background. Individual nuclei within this region
were identified, and average cell area calculated by dividing
the monolayer area by the nuclear count (Figure 1). Next,
scores were normalized using the CellHTS package [19]
within the online RNAi database FLIGHT [20] (Figure 1).
Results were then filtered to remove dsRNAs that have a pro-
found affect on cell number (Figure 1), which included many
housekeeping genes. Finally, manual curation was used to fil-
ter out dsRNAs displaying secondary phenotypes, including
defects in cell adhesion. The remaining scores were then
ranked based on normalized mean cell area, to reveal the 15
dsRNAs that act most potently to reduce S2R+ cell size (Table
1 and Additional data file 1), all of which are conserved
between fly and human.
Network analysis of this putative hit list in the database
FLIGHT [20] revealed a core set of genes that participate in
the Ras/MAPK signaling pathway (drk/Grb2,  csw/SHP-2,
Sos, Ras1, Dsor1/MEK and rl/ERK; Figure 1). In most cases,
Ras/MAPK signaling is thought to be activated downstream
of ligand binding to a receptor tyrosine kinase [21]. It was
notable, therefore, that the screen identified a single receptor
tyrosine kinase gene, Pvr, that exhibited a strong reduced cell
size phenotype (Table 1). Pvr is the sole member of the plate-
let-derived growth factor (PDGF)/vascular endothelial
growth factor (VEGF) family of receptors in Drosophila, and
has previously been implicated in a range of cellular func-
tions, including migration, proliferation and survival [22-31],
but not thus far in the regulation of cell size.
Of the remaining putative hits, only Rheb, a component of the
growth regulating Tor pathway [32], had a known signaling
function. Novel hits were diverse in functions and included
CG9306, which encodes a component of the electron trans-
port machinery, Nup44A, which encodes a nuclear pore com-
ponent, and several transcription factors. The screen also
identified a large number of housekeeping genes, such as
ribosomal components Rps8  and  Rps18  and proteosomal
components Prosalpha7 and Pomp, most of which led to a
reduction in both cell size and number (Additional data file 1).
However, given our focus on cell growth, we limited our fur-
ther analysis to delineation of the signaling pathway by which
Pvr and Ras1 regulate cell size.
Validation of hits affecting cell size
In order to reduce the likelihood of false positives resulting
from sequence-specific off-target effects, two non-overlap-
ping dsRNAs were used to validate each putative hit identi-
fied in the screen [33]. RNAi phenotypes for all components
of the canonical Ras/MAPK signaling pathway (Figure 2a)
were verified using a microscopy-based assay (Figure 2b) and
by using an electronic cell counter to directly measure cell vol-
umes (Figure 2c). This analysis revealed that dsRNAs target-
ing  Pvr,  Grb2,  Sos,  Ras1,  ERK  and  ksr  reduce cell size.
Conversely, RNAi-induced silencing of Gap1, a Ras1 GTPase
activating protein (GAP) that is a negative regulator of the
pathway, led to a significant increase in cell size. However,
RNAi-induced silencing of Raf  and  MEK, previously
described as members of the Ras/MAPK signaling pathway,
failed to generate equivalent changes in cell size, even when
targeted using different dsRNAs (data not shown). Why this
might be the case is explored below.
Pvf2 and Pvf3 redundantly activate Pvr to control cell 
size
In order to identify the upstream signal(s) that trigger the
Pvr-dependent increase in S2R+ cell size, we turned ourhttp://genomebiology.com/2009/10/2/R20 Genome Biology 2009,     Volume 10, Issue 2, Article R20       Sims et al. R20.3
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Workflow of the computational analysis of images from a high-content, genome-wide RNAi screen in Drosophila cell culture Figure 1
Workflow of the computational analysis of images from a high-content, genome-wide RNAi screen in Drosophila cell culture. Raw images of S2R+ cells 
stained for F-actin, microtubules and DNA were analyzed computationally to calculate the total monolayer area and mean cell area in each image (see 
Materials and methods for details). Image analysis scores were then normalized across screen plates to create z-scores (see Materials and methods for 
details). Hits were selected using a z-score threshold of -2 for mean cell area, and a monolayer area z-score of -2 to exclude images with low cell number 
where small cell size may reflect viability defects (green squares). This, approach yielded 73 putative hits (red triangles), which were examined for known 
physical and genetic interactions in FLIGHT [20].http://genomebiology.com/2009/10/2/R20 Genome Biology 2009,     Volume 10, Issue 2, Article R20       Sims et al. R20.4
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attention to the previously described Pvr ligands Pvf1, Pvf2
and Pvf3 [24]. Since the genes for none of these three ligands
were identified in the phenotypic screen (Additional data file
2), we tested for functional redundancy between the three lig-
ands using RNAi to silence the expression of Pvfs in combina-
tion. Whilst silencing of individual Pvfs failed to induce a
change in cell size, a significant reduction in cell size was
observed when Pvf2 and Pvf3 were silenced together (Figure
2d), suggesting that these two ligands act redundantly to acti-
vate Pvr. No such synergy was seen with Pvf1 and the other
ligands.
To verify this putative role for Pvf2 and Pvf3 in the control of
S2R+ cell size, cells were transiently transfected with Pvf-
containing plasmids. Pvf expression was then induced and
cell volumes were measured using an automatic cell counter.
Significantly, the expression of either Pvf2 or Pvf3 was suffi-
cient to induce a significant increase in the average size of
S2R+ cells relative to a green fluorescent protein (GFP) con-
trol (Figure 2e). By contrast, Pvf1 expression had no detecta-
ble effect on cell size (Figure 2e). Although it is unclear why
one ligand should be non-functional in this context, previous
studies have shown that different ligands operate in different
settings in vivo [26-28,30]. Importantly, the increase in cell
size induced by Pvf2/3 was observed across the population,
even though transfection efficiencies remained at approxi-
mately 20%. This implies that secreted Pvf2 and Pvf3 are able
to diffuse in the culture medium to trigger cell signaling in a
paracrine fashion, as has been previously suggested [29]. To
confirm that this effect of Pvfs on cell size was mediated by
the Pvr receptor, an epistasis experiment was carried out in
which  Pvr  RNAi cells were transfected with a construct
expressing  Pvf3  (Figure 2e), or a control plasmid. As
expected, this eliminated significant differences in cell size
between experimental and control populations, confirming
that Pvfs act via Pvr to alter cell size.
Pvr signaling controls cell growth
Changes in cell size can occur in the absence of alterations in
the rate of cell growth via an acceleration or delay of cell divi-
sion [34,35]. Such effects were clearly seen in the screen,
where the silencing of cdc25 (string) caused growing cells to
arrest in G2, resulting in a large increase in cell size over time
(yielding a mean cell area z-score of +13.51) and a concomi-
tant reduction in cell number. Conversely, the acceleration of
cell cycle progression induced by silencing a negative regula-
tor of the cell cycle, wee, reduced cell size (yielding a mean cell
area z-score of -1.53). Noticeably, however, this was not
accompanied by a reduction in cell number like that seen fol-
lowing Pvr or Ras RNAi (data not shown) [2].
Because of this link between cell cycle progression and cell
size, it was important to determine whether changes in cell
cycle progression contribute to the effects of Pvr/Ras signal-
ing on cell size. To do this, we used a FACS analysis to exam-
ine the cell cycle profile of cells compromised for Pvr/Ras
signaling. This revealed a significant increase in the propor-
tion of cells in G1 in cells treated with dsRNA targeting Pvr or
Ras (Figure 3a). This could be the result of a delay in the pro-
gression of cells from G1 into S-phase or the arrest of a sub-
population of cells at the G1/S transition. To determine which
is likely to be the case, in a second experiment we used the
incorporation of bromodeoxyuridine (BrdU) as a measure of
the proportion of cycling cells. BrdU was added to Pvr, Ras
Table 1
List of top hits from computational analysis of mean cell area in images from a high-content genome-wide RNAi screen
Fly gene Human homologue Z-score Function
Sos SOS1 -4.09 Ras signaling
drk GRB2 -3.73 Ras signaling
CG11294 CART1 -3.07 Transcription factor
gfzf GSTT1 -3.02 Glutathione transferase
Pvr PDGF/VEGF -2.92 Receptor tyrosine kinase
rl MAPK1 -2.80 Ras signaling
Sec61alpha SEC61A2 -2.66 Protein secretion
Rheb RHEB -2.52 Tor signaling
Nup44A SEH1L -2.47 Nuclear pore
Ras85D KRAS -2.30 Ras signaling
csw PTPN11 (SHP-2) -2.22 Ras signaling
CG9306 NDUFB9 -2.20 Mitochondrial electron transport
CG9300 NOL11 -2.15 Sugar transporter
fax C6orf168 -2.04 Axonogenesis
Dsor1 MAP2K1 -2.02 Ras signaling
This list was derived from an initial hit list (Additional data file 1) following the confirmation of phenotypes by visual inspection and the exclusion of 
genes causing other cell shape phenotypes. Genes participating in the Ras signaling pathway are highlighted in bold.http://genomebiology.com/2009/10/2/R20 Genome Biology 2009,     Volume 10, Issue 2, Article R20       Sims et al. R20.5
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and Rheb RNAi cells 3 days after dsRNA treatment. Cells were
then fixed and permeabilized 24 hours later so that incorpo-
rated BrdU could be visualized (Figure 3b). In each case, the
percentage of BrdU positive cells was similar to that of the
GFP RNAi control (>50%). These data strongly suggest that
Pvr/Ras silencing causes a shift in the relative timing of G1/S
and G2/M progression, without inducing a cell cycle arrest.
We then combined dsRNA targeting Pvr or other components
of the Ras/MAPK pathway (Sos, Ras1, ksr, Raf, MEK and
ERK) with string dsRNA to determine whether Pvr/Ras is
required for cell growth in S2R+ cells that are unable to cycle.
In each case, the FACS profile revealed a large G2 peak (data
not shown), and an accompanying reduction in BrdU incor-
poration between days 3-4 after dsRNA treatment (Figure
3b), as expected for a string dsRNA-induced G2/M arrest.
Significantly, however, dsRNAs targeting components of the
Pvr/Ras pathway caused a significant reduction in the size of
string RNAi cells (Figure 3c), indicating that the pathway is
required for cell growth in cells arrested in G2, as it is in
cycling cells. Taken together, these data suggest that the Pvr/
Ras pathway is rate-limiting for the growth (accumulation of
mass) of S2R+ cells and, either directly or indirectly, affects
the relative time cells spend in G1 and G2.
Tor but not insulin signaling is required for growth of 
S2R+ cells
Since Pvr has not been previously reported to control cell size,
we examined the role of established growth regulatory path-
ways in the S2R+ cell line. Previous studies have identified
the protein kinase Tor as a key regulator of cell growth in a
wide variety of eukaryotic systems [32]. In the canonical Tor
pathway, the small GTPase Rheb activates the Tor/Raptor
complex, which phosphorylates ribosomal S6-kinase to stim-
ulate cell growth [32]. However, our genome-wide RNAi
screen only identified a single member of the Tor pathway,
Rheb, as a putative regulator of cell size. A closer examination
of the screen data revealed that our failure to identify other
Pvr, Ras1 and the MAPK pathway control cell size in a Drosophila hemocyte-like cell line Figure 2
Pvr, Ras1 and the MAPK pathway control cell size in a Drosophila hemocyte-like cell line. (a) Schematic of canonical Ras/MAPK signaling. (b) Control and 
RNAi-treated S2R+ cells fixed and stained for microtubules (20× magnification). Pvr and Ras1 RNAi cause a decrease in cell area, whereas Gap1 RNAi 
causes an increase in cell area compared to control. (c-e) Charts of the mean percentage change in volume of RNAi treated or Pvf transfected S2R+ cells 
relative to control cells, as measured using a CASY counter. (c) Silencing of positive regulators of the Ras/MAPK pathway causes a reduction in cell 
diameter, whereas silencing of Gap1, a negative regulator of Ras1 signaling, causes an increase in cell diameter. (d) Silencing of Pvf1, 2 or 3 individually has 
no effect on cell volume, but silencing of Pvf2 and Pvf3 in combination significantly reduces cell size. (e) Over-expression of Pvf2 or Pvf3, but not Pvf1 leads 
to an increase in cell volume. This affect is dependent on Pvr. Error bars indicate the standard error of the mean.http://genomebiology.com/2009/10/2/R20 Genome Biology 2009,     Volume 10, Issue 2, Article R20       Sims et al. R20.6
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components of the Tor signaling pathway was due in part to
the stringent cut-off employed in the computational analysis
to reduce the number of false positives. In fact, Tor, Raptor
and S6k silencing was associated with a small, but measura-
ble decrease in cell area (z less than -1.6 in each case), sug-
gesting that the Tor pathway does indeed play a role in the
control of cell growth in S2R+ cells. To confirm this, we gen-
erated non-overlapping dsRNAs for each pathway compo-
nent and directly measured cell sizes using an electronic cell
analyzer. All core members of the canonical Tor pathway dis-
played the expected RNAi phenotype. Silencing positive reg-
ulators of the pathway (Rheb, Tor, Raptor and S6k) led to a
significant decrease in cell size (Figure 3d). Conversely, dsR-
NAs targeting either of the two negative regulators of the
pathway, Tsc1 and Tsc2 (which together form a Rheb GAP),
increased cell size (Figure 3d). Furthermore, FACS analysis
revealed that Rheb or Tor RNAi leads to an increase in the
proportion of cells in G1, similar to that seen in Pvr RNAi cells
(Figure 3a). These results confirm that the canonical Tor
pathway controls cell growth in S2R+ cells, as previously
demonstrated in S2 cells [36,37] and in vivo [10].
Tor has been shown to act downstream of insulin-induced
receptor tyrosine kinase (RTK) signaling to control Dro-
sophila cell growth in vivo [10]. Moreover, insulin has been
shown to stimulate the growth of Drosophila cells in vivo [38]
and in fly cell culture [39]. This signal is mediated by the insu-
lin receptor (InR). The activated receptor recruits the insulin
receptor substrate (IRS) adaptor protein, which binds the
regulatory (p60) subunit of class I PI3K, enabling the cata-
lytic (p110) subunit to convert the phospholipid PIP2 to PIP3
in the membrane. PIP3 then recruits several downstream tar-
Pvf/Pvr signaling controls cell growth and G1/S progression Figure 3
Pvf/Pvr signaling controls cell growth and G1/S progression. (a) FACS analysis of RNAi-treated S2R+ cells. Control cells typically exhibit a large G2 peak 
and a much smaller G1 peak. However, treatment with dsRNA to Pvf2/3, Pvr, Ras1 or Rheb causes a significant increase in the G1 peak with a concurrent 
decrease in the G2 peak. (b) BrdU labeling of cells treated with dsRNA targeting the Pvr/Ras pathway suggests that cells are still cycling. Parallel silencing 
of Cdc25 expression blocks cell cycle progression as expected. (c) Cdc25 (String) RNAi causes a significant increase in cell volume. This increase is 
suppressed by simultaneous silencing of Pvr or members of the Ras/MAPK pathway. (d) Chart of the mean percentage change in cell volume of RNAi 
treated S2R+ cells relative to control (LacZ RNAi) cells. Upstream components of the insulin signaling pathway do not affect cell size. However, 
downstream components (PDK1, Akt) exhibit a small effect. Silencing of negative regulators of both insulin (Pten) and Tor signaling (Tsc1/Tsc2) results in a 
significant increase in cell size. Conversely, silencing of positive regulators of Tor signaling reduces cell size. Error bars indicate the standard error of the 
mean.http://genomebiology.com/2009/10/2/R20 Genome Biology 2009,     Volume 10, Issue 2, Article R20       Sims et al. R20.7
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gets, most notably PDK1, to the membrane, to induce the
phosphorylation and activation of Akt/PKB, which goes on to
inactivate Tsc1/2 to stimulate the Tor pathway. In analyzing
the role of insulin signaling in the growth of S2R+ cells, we
first verified that insulin is able to alter their growth. As
expected for a cell line with an intact insulin signaling path-
way, the addition of insulin to the medium of these cells
increased the rate of proliferation and average cell volume
(data not shown). This does not mean, however, that insulin
signaling is required for normal S2R+ cell growth. To test
whether or not this was the case, we measured cell size follow-
ing RNAi-induced silencing of pathway components. Knock-
ing down of the upstream components InR, IRS, p60 or p110
had no effect on cell size (Figure 3d), even though this was
sufficient to fully (InR,  IRS,  p60) or partially (p110) [40]
attenuate the insulin-induced phospho-Akt response (data
not shown), while PDK1  or  Akt  silencing induced a small
reduction in cell size (Figure 3d). These experiments suggest
that while the insulin pathway is operational in S2R+ cells, it
is not rate-limiting for size control in this cell line under nor-
mal cell culture conditions.
The PI3K and MAPK pathways act in parallel to relay 
the Pvr growth signal
Having established important roles for Pvr and Ras1 in the
regulation of S2R+ cell growth, an RNAi epistasis analysis
was used in an attempt to delineate downstream signaling
events in more detail, and to better understand the reason for
the minor phenotypic consequences of using RNAi to deplete
several well-established Ras targets. To begin this analysis we
used negative regulators of cell growth signaling in this sys-
tem, Gap1 and Tsc2, as genetic landmarks to position positive
regulators within the pathway.
We began by using RNAi to modify the Gap1 phenotype. As
expected, the Gap1 RNAi-induced increase in cell size could
be suppressed by ERK RNAi, and reversed by dsRNA-medi-
ated silencing of Ras1, and by reductions in the expression of
downstream components of the Tor signaling pathway, Rheb,
Tor and S6K (Figure 4a). Interestingly, however, direct tar-
gets of Ras1, Raf and p110 only partially suppressed the
effects of Gap1 RNAi (Figure 4a), mirroring the results of sin-
gle  Raf  and  p110  RNAi experiments (Figures 2c and 3c).
These results suggest that both the MAPK and PI3K pathways
contribute to the communication of the growth signal down-
stream of Ras1.
We then repeated this epistasis analysis in a background in
which the gene for the Rheb GAP Tsc2 was silenced, deregu-
lating Rheb activity to increase cell growth (Figure 3c). Once
again, although several dsRNAs (Ras1, p110 or Akt) reduced
the extent of the cell size increase seen following Tsc2 RNAi,
the Tsc2 phenotype dominated in each case (Figure 4b), plac-
ing these genes genetically upstream of Tsc2. Although differ-
ent pathway members (for example, Pvr versus Ras1)
exhibited minor differences in their ability to suppress the
Tsc2 phenotype, we believe that this is likely to reflect the fact
that epistasis experiments are inherently sensitive to gene-
specific differences in the kinetics of RNAi knockdown. Only
Rheb and S6k strongly attenuated the Tsc2 phenotype, imply-
ing that they function downstream of Tsc2, as previously
reported [32]. Taken together (compare Figure 4a and 4b),
these results suggest that Pvr/Ras signaling is likely to oper-
ate upstream of the Tor pathway in controlling cell growth in
S2R+ cells, although we cannot exclude the possibility that
Ras and Tor signaling operate in parallel.
These results focused our attention on the function of inter-
mediate pathway components that have a minor impact on
cell growth when targeted using RNAi (Figures 2c and 3d).
Since Ras has been shown to signal directly to both PI3K and
Raf in other systems [41], we decided to use combinatorial
RNAi experiments to test whether p110 and Akt might coop-
erate with Raf in relaying the growth signal downstream of
Ras1 in S2R+ cells (Figure 4c). This analysis revealed a set of
additive and synergistic interactions between components of
the MAPK and PI3K pathways (Figure 4c, d). This was clear-
est for p110, since the reduction in cell size observed following
silencing of p110 together with either Raf, ksr or ERK was
equal to or greater than the sum of phenotypes observed in
RNAi experiments targeting these genes independently (Fig-
ure 4c, d and data not shown). In addition, there was an addi-
tive effect of targeting Akt and these components of the
MAPK pathway. Since InR RNAi failed to enhance the effect
of Raf silencing (Figure 4c), this synergy between Raf and
p110/Akt is unlikely to be the result of a parallel input from
insulin signaling. Instead, because p110/Akt RNAi did not
synergize with Pvr and Ras1 RNAi (Figure 4d), the PI3K path-
way likely functions downstream of Ras1 in this growth assay,
as has been described in other systems [41]. Taken together,
these results suggest that signals relayed by both the MAPK
and PI3K pathways cooperate in growth signaling. Indeed,
both Akt and ERK have been shown to phosphorylate and
inactivate Tsc2 in mammalian systems [42-45]. Thus, the
Tsc1/Tsc2 complex may serve as a hub to integrate growth
signals.
Pvr controls cell size in other Drosophila cell lines and in 
larval hemocytes
Having identified a Pvr signaling pathway that is rate-limiting
for the growth of the S2R+ hemocyte-derived Drosophila cell
line, we extended this analysis to investigate possible implica-
tions for the growth of other cells. First, we examined the
effects of Pvr silencing in a variety of other Drosophila cell
lines. Pvr showed a strong cell size phenotype in both the S2
hemocyte cell line and the neuronal cell line ML-DmBG3-c2
(Figure 5a), implying that Pvf/Pvr autocrine signaling is a
common feature of the growth of Drosophila cell lines in cul-
ture.
To test whether Pvr might play a similar role in the regulation
of cell size in vivo, we extracted hemocytes from Drosophilahttp://genomebiology.com/2009/10/2/R20 Genome Biology 2009,     Volume 10, Issue 2, Article R20       Sims et al. R20.8
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larvae containing Pvr or Ras RNAi constructs under the con-
trol of two different hemocyte drivers (Hml-Gal4 and Cg-
Gal4). In both cases, we used upstream activation sequence
(UAS)-GFP as a marker to confirm that transgenes were
being expressed in these primary cells. In order to estimate
cell size, mean cell area was measured after GFP-labeled cells
had been given time to spread on an adhesive concanavilin A-
coated surface. As controls, we also measured the spread area
of cells lacking either the driver (data not shown) or the RNAi
hairpin. In this experiment, Pvr silencing or the expression of
a dominant negative Pvr or Ras construct led to a significant
reduction in the size and number of hemocytes relative to
control experiments (Figure 5b and data not shown).
Although Ras1 over-expression has previously been shown to
cause an increase in larval hemocyte number [46], which nec-
essarily requires coincident cell growth and division, these
data suggest that Ras/MAPK signaling also plays a role in
mass accumulation. Thus, Pvr and Ras1 control the growth,
proliferation [29] and viability [22] of Drosophila hemocytes
in vivo.
Discussion
I n  t h i s  s t u d y ,  w e  h a v e  u s e d  a n  a u t o m a t e d  i m a g e  a n a l y s i s
pipeline to screen through images from a high-content,
genome-wide RNAi screen for genes whose activity is rate-
limiting for the growth of Drosophila cells in culture. In doing
so, we identified a number of known and novel genes regulat-
ing cell size. Interestingly, this screen identified a novel role
for autocrine signaling through Pvfs and the receptor tyrosine
Pvf/Pvr signaling activates a network of signaling modules upstream of the Tor pathway Figure 4
Pvf/Pvr signaling activates a network of signaling modules upstream of the Tor pathway. (a) Gap1 RNAi epistasis. Ras1, Rheb, Tor and S6k dominate in their 
effect on cell size, ERK suppresses the Gap1 RNAi phenotype, whereas Raf, p110 and Akt only partially ameliorate the large increase in cell size seen 
following Gap1 RNAi. The insulin receptor has little effect in this assay. (b) Tsc2 RNAi epistasis. Rheb and S6k dominate, placing them genetically 
downstream of Tsc2. Pvr, Ras1 and members of the MAPK and PI3K pathways fail to have a dramatic impact on the Tsc2 RNAi phenotype. (c) Raf (pole 
hole) RNAi epistasis. Silencing of Raf leads to a minor reduction in cell size. However, silencing of Raf in conjuction with p110 or Akt1 causes a large 
reduction in cell size, like that seen in Pvr, Ras, Tor, Rheb, and S6K RNAi experiments. (d) MAPK and PI3K pathway genetic interactions. Raf, ERK and Ksr 
all show additive or synergistic genetic interactions with p110 and Akt1, but not with InR. Furthermore, these genetic interactions are stronger than those 
seen when combining p110 or Akt1 dsRNA with dsRNA targeting upstream or downstream pathway components of this putative growth signaling 
network (Pvr/Ras1 and Tor/S6k, respectively). Error bars indicate the standard error of the mean.http://genomebiology.com/2009/10/2/R20 Genome Biology 2009,     Volume 10, Issue 2, Article R20       Sims et al. R20.9
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kinase Pvr in the control of the autonomous growth of Dro-
sophila cells in culture. Previous studies have suggested roles
for Pvf/Pvr signaling in the control of cell migration
[23,27,30], morphogenesis [25,26,31], cell viability [22] and
proliferation [28,29]. However, to our knowledge this is the
first clear example of this pathway controlling cell size. This
reduction in the size of Pvr RNAi cells was accompanied by a
reduction in cell proliferation, as revealed by reduced cell
numbers in the absence of significant apoptosis (data not
Pvr controls cell growth in a variety of cell lines and in Drosophila hemocytes Figure 5
Pvr controls cell growth in a variety of cell lines and in Drosophila hemocytes. (a) F-actin staining of Drosophila S2 and ML-DmBG3-c2 (neuronal) cells 
treated with dsRNA to LacZ or Pvr reveals a reduction in cell size in Pvr RNAi cells relative to control. (b) Pvr and Ras1 dominant negative constructs were 
expressed in larval hemocytes in vivo using the Cg-Gal4 driver. Hemocytes were extracted, allowed to adhere to conconavalin A and then fixed and stained 
for F-actin. Cell area was measured from images of hemocytes (see Materials and methods). Both Pvr and Ras1 DN constructs caused a significant 
reduction in hemocyte cell area relative to wild-type (WT). (c) Driving expression of Pvr RNAi constructs in hemocytes using either Cg-Gal4 or Hml-Gal4 
causes a significant decrease in cell size relative to control (driver or hairpin only) cells. Cells were stained for F-actin. Control and experimental images in 
(b, c) were taken at the same magnification. Error bars indicate the standard error of the mean.http://genomebiology.com/2009/10/2/R20 Genome Biology 2009,     Volume 10, Issue 2, Article R20       Sims et al. R20.10
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shown), and by a delay in the passage of cells through G1 and
into S phase.
One interpretation for these observations is that Pvr knock-
down might trigger autophagy in S2R+ cells. Indeed, one of
the first responses that cells exhibit when confronted with
unfavorable growth conditions is to shrink in size and trigger
autophagy to meet their energy demand during poor nutri-
tional conditions. It is also possible that a loss of cell mass fol-
lowing Pvr/Ras RNAi contributes to the small cell phenotype,
should this growth signaling pathway regulate both growth
and autophagy in S2R+ cells.
Next, we used an RNAi epistasis analysis to delineate this Pvr
growth-signaling pathway. Interestingly, whilst the effects of
dsRNAs targeting upstream components (Pvr, Sos and Ras)
of the Pvr/Ras pathway were much greater than the effects of
targeting individual downstream components (Raf, Ksr and
ERK), dramatic reductions in cell size were observed when
dsRNAs were combined that target both PI3K and MAPK
arms of the downstream signaling pathway (Figure 4d).
These data suggest that the growth signal downstream of Ras
requires the combined activit y  o f  d o w n s t r e a m  P I 3 K  a n d
MAPK signaling modules. Our data also suggest that these
signaling pathways act upstream of the Tor pathway in S2R+
cells, as shown in other systems [42-45]. Although this type of
growth signal integration has not been previously reported in
Drosophila, Ras1 has been shown to influence both growth
and G1/S cell cycle progression in vivo [47] and Ras1 has been
shown to crosstalk to dp110 in the control of in vivo cell and
tissue growth [6].
In the context of development, crosstalk between signaling
pathways, like that seen in our analysis, could help to inte-
grate information from different types of intrinsic and extrin-
sic cues in order to aid cellular decision making. Alternatively,
as seen in this study, the use of parallel signaling modules
(PI3K and MAPK in this case) may serve to buffer cellular
behavior from changes in the relative levels of different input
signals. However, in vivo, we would not expect to observe
many instances of autocrine growth signaling, since this is
inherently hard to regulate. Indeed, in situ hybridization
studies in Drosophila embryos suggest that receptors such as
Pvr are expressed in specific populations of cells, such as
hemocytes, that do not express any of the corresponding lig-
ands Pvf1-3 [23]. Similarly, Pvf secretion is restricted to par-
ticular compartments in pupal stages, and when deregulated
can cause tumorous growth [29]. These data suggest that
mutations leading to Pvr and Pvfs co-expression may con-
tribute to the establishment of autonomous cell growth dur-
ing the establishment of Drosophila cell lines in media based
on bovine serum, which lacks strong activators of ERK and
PI3K signaling [40]. In the future it will therefore be interest-
ing to investigate the mechanisms used to ensure that the in
vivo expression of ligand receptor pairs, like Pvfs and Pvr,
remains mutually exclusive, and to reveal how these controls
are deregulated during the establishment of a Drosophila cell
line. We would expect this information to be useful in the
establishment of new cell lines and in furthering our under-
standing of the processes leading to the deregulated expres-
sion of ligand-receptor pairs during the development of a
variety of cancers [48,49].
Conclusion
This study presents evidence for a novel role for autocrine
Pvf/Pvr signaling in cell growth, both in cell culture and in
vivo. The Drosophila homologue of the mammalian PDGF/
VEGF receptor family acts upstream of Ras, and diverging
MAPK and PI3K signaling modules. Since Pvf2/3 and Pvr
show mutually exclusive patterns of expression in vivo, these
data suggest that co-expression of this receptor-ligand pair
plays a key role in driving cell autonomous growth during the
establishment of Drosophila cell lines, as has been suggested
to occur during tumor development.
Materials and methods
Drosophila cell culture
S2R+ cells were grown in Schneider's medium (Invitrogen,
Carlsbad, California, USA) or Shields and Sang M3 insect
medium (Sigma-Aldrich, St Louis, Missouri, USA) with 10%
heat-inactivated fetal bovine serum (Sigma-Aldrich, St Louis,
Missouri, USA) and penicillin-streptomycin (Sigma-Aldrich).
S 2  c e l l s  w e r e  g r o w n  i n  I n sectExpress media with L-
Glutamine (PAA Laboratories, Pasching, Austria). ML-
DmBG3-c2 cells were cultured in M3 media supplemented
with fetal bovine serum, antibiotics and 10 μg/ml bovine
insulin (Sigma-Aldrich, St Louis, Missouri, USA). Drosophila
S2R+ cells were transiently transfected using the CellFectin
(Invitrogen, Carlsbad, California, USA) lipid transfection rea-
gent according to the manufacturer's protocol. Where neces-
sary, gene expression was induced by addition of 1 mM CuSO4
solution.
RNAi
dsRNA templates were amplified by PCR from genomic DNA
using pairs of gene-specific primers. dsRNA synthesis was
performed using the T7 Megascript kit (Applied Biosystems,
Foster City, California, USA). RNA preparations were puri-
fied using PCR96 cleanup plates (Millipore, Billerica, Massa-
chusetts, USA) attached to a vacuum pump. Purified RNAs
were resuspended in Tris-EDTA buffer (TE) and annealed by
heating at 65°C for 10 minutes and cooling slowly. Typically,
cells suspended in serum-free medium were mixed with
dsRNA to give a final concentration of 30 μg/ml then plated
into tissue culture dishes and incubated at 24°C for 30 min-
utes. Subsequently, three volumes of complete medium was
added and cells were grown for 5-7 days at 24°C to allow for
protein turnover [50].http://genomebiology.com/2009/10/2/R20 Genome Biology 2009,     Volume 10, Issue 2, Article R20       Sims et al. R20.11
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Cytoskeletal staining and image acquisition
Cells in 384-well plates were washed with phosphate buffered
saline (PBS) and fixed for 10 minutes in 4% formaldehyde
(Polyscience, Niles, Illinois, USA). After fixation cells were
permeablized by washing with PBS containing 0.1% Triton-
X-100 (PBS-T), then blocked with 5% bovine serum albumin
(Sigma) in PBS-T for 20 minutes. For staining, cells were first
incubated with 1:500 α-Tubulin antibody (Sigma) in PBS-T
containing 1% bovine serum albumin overnight at 4°C. Cells
were then washed twice with PBS-T and incubated with
fluoro-isothiocyanate (FITC) anti-mouse IgG secondary anti-
body (The Jackson Laboratory, Bar Harbor, Maine, USA)
combined with TRITC-Phalloidin (Sigma) and DAPI (Sigma)
for 2 hours. For BrdU experiments, BrdU was added to the
culture medium 3 days after the addition of RNAi. Cells were
then fixed, acid washed and stained 24 hours later, using
TRITC-labeled anti-BrdU antibodies to reveal the extent of
BrdU incorporation into DNA. In each case, fluorescent
images were acquired using an automated Nikon TE2000E
microscope with a 20× objective and HTS (high throughput
screening) MetaMorph software (Molecular Devices, Sunny-
vale, California, USA) running an automated stage and shut-
ter (Prior, Cambridge, UK), and a Roper CoolSNAP cooled-
coupled device camera.
Computational image analysis and score normalization
Image analysis was performed using the image analysis
toolkit in Matlab (Mathworks, Natick, Massachusett, USA).
F-actin and microtubule stained images were processed to
remove cell clumps and background, leaving the cell monol-
ayer. DNA stained images were segmented to identify nuclei
in the cell monolayer. Mean cell area was calculated as the
area of the monolayer divided by the number of nuclei. Raw
scores from image analysis were normalized to correct for
systematic differences between assay plates. Normalization
was performed using the CellHTS package [19], part of the
Bioconductor suite of biological data analysis packages for the
R statistical computing environment. Briefly, mean cell area
scores were normalized using median centering per plate, and
screen z-scores were calculated using the screen median and
the median absolute deviation (MAD). Replicate scores from
different image sites in the same well were summarized using
the closest to zero function (equivalent to taking the mini-
mum, independent of sign) to calculate a single z-score for
each screen well. The proportion of nuclei that had undergone
division was established by computational image analysis of
BrdU and DAPI images.
Cell size and cell cycle measurements
Cell volume was measured using a CASY cell counter and
analysis system (Scharfe System, Reutlingen, Germany).
Cells diluted 1:101 in CasyTon reagent (Scharfe System) were
measured in triplicate. The mean cell volume for each treat-
ment was calculated as the average peak volume from three
independent readings. For each experiment the peak cell vol-
ume (the peak in the histogram of individual cell volumes) for
at least ten control wells measured in triplicate was used to
establish a solid baseline for comparison. Since control cell
size varied between experiments, it was necessary to normal-
ize scores for each experiment before summarization. Thus,
volumes were converted to the percentage of mean control
cell volume. Percentage of mean control cell volume from at
least two independent experiments were averaged and used
to construct bar charts. For cell cycle profiles, the cells were
fixed in 70% ethanol at -20°C and subsequently resuspended
in PBS containing 50 μg/ml propidium iodide and 60 μg/ml
RNaseA. The profiles were acquired on a FACSanto anlyzer,
using FACSDiva software (Becton Dickinson, Franklin Lakes,
New Jersey, USA). All cells were in log growth phase during
the course of the experiments.
In vivo methods
Cg-Gal4, Hml-Gal4, UAS-GFP and UAS-RasDN lines were
obtained from the Bloomington stock centre. The UAS-
PvrDN line was a gift from P Rorth and Pvr RNAi lines were
gifts from Benny Shilo. Late third instar larvae were washed
and the integument was disrupted in the latero-posterior
region without organ disruption. The circulating hemocytes
were directly collected in M3 medium. In each case, pooled
hemocytes from several larvae were plated on conconavalin A
coated 384-well plates and allowed to spread flat on this sub-
strate for 2 hours. Attached hemocytes were fixed, stained
and imaged as above and cell area was measured computa-
tionally. UAS-GFP was used to confirm Gal4 expression in
larval hemocytes.
Abbreviations
BrdU: bromodeoxyuridine; dsRNA: double-stranded RNA;
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mitogen-activated protein kinase; PBS: phosphate-buffered
saline; PDGF: platelet-derived growth factor; PI3K: phospho-
inositide-3-kinase; RNAi: RNA interference; UAS: upstream
activation sequence; VEGF: vascular endothelial growth fac-
tor.
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Additional data files
The following additional data are available with the online
version of this paper. Additional data file 1 describes in full
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from a high-content genome-wide RNAi screen. Additional
data file 2 provides details of computational image analysis
scores for all MAPK, Tor and insulin pathway components.
Additional data file 1 Top cell size hits from computational analysis of images from a  high-content genome-wide RNAi screen This list was generated using a mean cell area z-score threshold of  less than -2. dsRNAs giving rise to visually confirmed phenotypes  are highlighted in yellow. Columns J-L: 'Y' indicates a hit, 'N' indi- cates that a dsRNA was screened but not hit and '-' indicates that no  dsRNA targeting the gene in question was screened. Click here for file Additional data file 2 Computational image analysis scores for all MAPK, Tor and insulin  pathway components Columns I-K: 'Y' indicates a hit, 'N' indicates that a dsRNA was  screened but not hit and '-' indicates that no dsRNA targeting the  gene in question was screened. All image analysis scores along with  original images and dsRNA primer and amplicon details from the  entire screen are available online in the FLIGHT database [20]. Click here for file
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